{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:44:30Z","timestamp":1767383070307,"version":"build-2065373602"},"reference-count":73,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"],"award-info":[{"award-number":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"]}]},{"name":"the Research Fund for International Scientists of National Natural Science Fund of China","award":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"],"award-info":[{"award-number":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"]}]},{"name":"the National Natural Science Foundation of China","award":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"],"award-info":[{"award-number":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"]}]},{"name":"the Science and Technology Development Project of Jilin Province","award":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"],"award-info":[{"award-number":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"]}]},{"name":"the \u201cMedicine + X\u201d Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University","award":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"],"award-info":[{"award-number":["2021YFC2301500","82350710801","31970888","82002138","20210402031GH","2022JBGS05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Viral infection generally induces polyclonal neutralizing antibody responses. However, how many lineages of antibody responses can fully represent the neutralization activities in sera has not been well studied. Using the newly designed stable HIV-1 Env trimer as hook, we isolated two distinct broadly neutralizing antibodies (bnAbs) from Chinese rhesus macaques infected with SHIV1157ipd3N4 for 5 years. One lineage of neutralizing antibodies (JT15 and JT16) targeted the V2-apex in the Env trimers, similar to the J038 lineage bnAbs identified in our previous study. The other lineage neutralizing antibody (JT18) targeted the V3 crown region in the Env, which strongly competed with human 447-52D. Each lineage antibody neutralized a different set of viruses. Interestingly, when the two neutralizing antibodies from different lineages isolated from the same macaque were combined, the mixture had a neutralization breath very similar to that from the cognate sera. Our study demonstrated that a minimum of two different neutralizing antibodies can fully recapitulate the serum neutralization breadth. This observation can have important implications in AIDS vaccine design.<\/jats:p>","DOI":"10.3390\/ijms25137200","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T12:58:42Z","timestamp":1719925122000},"page":"7200","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recapitulation of HIV-1 Neutralization Breadth in Plasma by the Combination of Two Broadly Neutralizing Antibodies from Different Lineages in the Same SHIV-Infected Rhesus Macaque"],"prefix":"10.3390","volume":"25","author":[{"given":"Yanxin","family":"Gai","sequence":"first","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Gao","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Mou","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chumeng","family":"Yang","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libian","family":"Wang","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanshan","family":"Ji","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Gu","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9202-677X","authenticated-orcid":false,"given":"Chu","family":"Wang","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7739-1386","authenticated-orcid":false,"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"},{"name":"Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China"},{"name":"Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou 510632, China"},{"name":"Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, Jinan University, Ministry of Education, Guangzhou 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"ref_1","unstructured":"UNAIDS (2023, November 24). UNAIDS Fact-Sheet 2022. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/JVI.00198-11","article-title":"The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection","volume":"85","author":"Gray","year":"2011","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0000000000000106","article-title":"Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection","volume":"28","author":"Hraber","year":"2014","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Landais, E., Huang, X., Havenar-Daughton, C., Murrell, B., Price, M.A., Wickramasinghe, L., Ramos, A., Bian, C.B., Simek, M., and Allen, S. (2016). Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005369"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12977-018-0443-0","article-title":"Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers","volume":"15","author":"Landais","year":"2018","journal-title":"Retrovirology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.02.006","article-title":"Reconstitution and characterization of antibody repertoires of HIV-1-infected \u201celite neutralizers\u201d","volume":"118","author":"Sun","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12509","article-title":"Antibody-virus co-evolution in HIV infection: Paths for HIV vaccine development","volume":"275","author":"Bonsignori","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1570162X15666171124122044","article-title":"The Neutralizing Antibody Response to the HIV-1 Env Protein","volume":"16","author":"Moore","year":"2018","journal-title":"Curr. HIV Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Griffith, S.A., and McCoy, L.E. (2021). To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.708227"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12977-018-0453-y","article-title":"The expanding array of HIV broadly neutralizing antibodies","volume":"15","author":"McCoy","year":"2018","journal-title":"Retrovirology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure","volume":"48","author":"Kwong","year":"2018","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12977-018-0457-7","article-title":"HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth","volume":"15","year":"2018","journal-title":"Retrovirology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14760584.2019.1690458","article-title":"Strategies for inducing effective neutralizing antibody responses against HIV-1","volume":"18","author":"Sliepen","year":"2019","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101428","DOI":"10.1016\/j.smim.2020.101428","article-title":"Antibody-guided structure-based vaccines","volume":"50","author":"Kwong","year":"2020","journal-title":"Semin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2019.06.030","article-title":"Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization","volume":"178","author":"Kong","year":"2019","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20077","DOI":"10.1073\/pnas.1919329117","article-title":"Optimizing immunization protocols to elicit broadly neutralizing antibodies","volume":"117","author":"Sprenger","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eabk1533","DOI":"10.1126\/scitranslmed.abk1533","article-title":"Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env","volume":"13","author":"Escolano","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eadd6502","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"Scheid","year":"2009","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1128\/JVI.05363-11","article-title":"Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals","volume":"85","author":"Tomaras","year":"2011","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chom.2015.08.006","article-title":"Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses","volume":"18","author":"Moody","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chukwuma, V.U., Kose, N., Sather, D.N., Sapparapu, G., Falk, R., King, H., Singh, V., Lampley, R., Malherbe, D.C., and Ditto, N.T. (2018). Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. PloS ONE, 13.","DOI":"10.1371\/journal.pone.0209437"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00878-18","DOI":"10.1128\/JVI.00878-18","article-title":"HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes","volume":"92","author":"Ditse","year":"2018","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100314","DOI":"10.1016\/j.xcrm.2021.100314","article-title":"A diverse collection of B cells responded to HIV infection in infant BG505","volume":"2","author":"Simonich","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"van Schooten, J., Schorcht, A., Farokhi, E., Umotoy, J.C., Gao, H., van den Kerkhof, T., Dorning, J., Rijkhold Meesters, T.G., van der Woude, P., and Burger, J.A. (2022). Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010945"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Walker, L.M., Simek, M.D., Priddy, F., Gach, J.S., Wagner, D., Zwick, M.B., Phogat, S.K., Poignard, P., and Burton, D.R. (2010). A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001028"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/s41467-023-42906-y","article-title":"Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals","volume":"14","author":"Kreer","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.chom.2023.05.025","article-title":"Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning","volume":"31","author":"Radford","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.coviro.2021.09.015","article-title":"Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination","volume":"51","author":"Mu","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/21645515.2016.1276138","article-title":"Progress in HIV vaccine development","volume":"13","author":"Hsu","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tibtech.2007.05.004","article-title":"HIV\/AIDS: Un search of an animal model","volume":"25","author":"Ambrose","year":"2007","journal-title":"Trends Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-13-0484-2_5","article-title":"Monkey Models and HIV Vaccine Research","volume":"1075","author":"Chen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14760584.2019.1557521","article-title":"Accelerating HIV vaccine development using non-human primate models","volume":"18","author":"Rahman","year":"2019","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/JVI.02898-15","article-title":"Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques","volume":"90","author":"Jia","year":"2016","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/j.celrep.2020.02.061","article-title":"Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines","volume":"30","author":"Nogal","year":"2020","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e61991","DOI":"10.7554\/eLife.61991","article-title":"A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch","volume":"9","author":"Wang","year":"2020","journal-title":"eLife"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Charles, T.P., Burton, S.L., Arunachalam, P.S., Cottrell, C.A., Sewall, L.M., Bollimpelli, V.S., Gangadhara, S., Dey, A.K., Ward, A.B., and Shaw, G.M. (2021). The C3\/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009257"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eabd2638","DOI":"10.1126\/science.abd2638","article-title":"Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth","volume":"371","author":"Roark","year":"2021","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"van Schooten, J., van Haaren, M.M., Li, H., McCoy, L.E., Havenar-Daughton, C., Cottrell, C.A., Burger, J.A., van der Woude, P., Helgers, L.C., and Tomris, I. (2021). Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009736"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.cell.2021.04.042","article-title":"Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies","volume":"184","author":"Williams","year":"2021","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAD.0000000000001724","article-title":"Development of broad neutralization activity in simian\/human immunodeficiency virus-infected rhesus macaques after long-term infection","volume":"32","author":"Gao","year":"2018","journal-title":"AIDS"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2200063","DOI":"10.1002\/advs.202200063","article-title":"Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2","volume":"9","author":"Gao","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gao, N., Gai, Y., Meng, L., Wang, C., Zhang, X., Wang, W., Qin, C., Yu, X., and Gao, F. (2020). Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques. Viruses, 12.","DOI":"10.3390\/v12020163"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1038\/ncomms12040","article-title":"Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability","volume":"7","author":"Kong","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"Sok","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"Kong","year":"2016","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"van Gils, M.J., van den Kerkhof, T.L., Ozorowski, G., Cottrell, C.A., Sok, D., Pauthner, M., Pallesen, J., de Val, N., Yasmeen, A., and de Taeye, S.W. (2016). An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability. Nat. Microbiol., 2.","DOI":"10.1038\/nmicrobiol.2016.199"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","volume":"509","author":"Schramm","year":"2014","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.molimm.2004.09.027","article-title":"Despite extensive similarity in germline DH and JH sequence, the adult Rhesus macaque CDR-H3 repertoire differs from human","volume":"42","author":"Link","year":"2005","journal-title":"Mol. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chernyshev, M., Kaduk, M., Corcoran, M., and Karlsson Hedestam, G.B. (2021). VDJ Gene Usage in IgM Repertoires of Rhesus and Cynomolgus Macaques. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.815680"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"Gorny","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/aid.2008.0188","article-title":"Worldwide distribution of HIV type 1 epitopes recognized by human anti-V3 monoclonal antibodies","volume":"25","author":"Cardozo","year":"2009","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.str.2009.09.012","article-title":"Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: Implications for design of V3-based immunogens","volume":"17","author":"Burke","year":"2009","journal-title":"Structure"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wesley, M.S., Chiong, K.T., Seaton, K.E., Arocena, C.A., Sawant, S., Hare, J., Hernandez, K., Rojas, M., Heptinstall, J., and Beaumont, D. (2021). Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.709994"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kochina, E.A., Urusov, F.A., Kruglov, A.A., Glazkova, D.V., Shipulin, G.A., and Bogoslovskaya, E.V. (2022). Double and Triple Combinations of Broadly Neutralizing Antibodies Provide Efficient Neutralization of All HIV-1 Strains from the Global Panel. Viruses, 14.","DOI":"10.3390\/v14091910"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1128\/JVI.01012-16","article-title":"Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding","volume":"90","author":"Longo","year":"2016","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes","volume":"89","author":"Kong","year":"2015","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wagh, K., Bhattacharya, T., Williamson, C., Robles, A., Bayne, M., Garrity, J., Rist, M., Rademeyer, C., Yoon, H., and Lapedes, A. (2016). Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005520"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.4049\/jimmunol.1502543","article-title":"High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence","volume":"196","author":"Wang","year":"2016","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.celrep.2017.02.003","article-title":"Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates","volume":"18","author":"Saunders","year":"2017","journal-title":"Cell Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cai, F., Chen, W.H., Wu, W., Jones, J.A., Choe, M., Gohain, N., Shen, X., LaBranche, C., Eaton, A., and Sutherland, L. (2021). Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009624"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4049\/jimmunol.2001082","article-title":"Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor","volume":"206","author":"Spencer","year":"2021","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency","volume":"90","author":"Bhiman","year":"2016","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jim.2012.09.003","article-title":"Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells","volume":"386","author":"Sundling","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies","volume":"158","author":"Liao","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_73","first-page":"491","article-title":"Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs","volume":"19","author":"Zhang","year":"2013","journal-title":"J. Pept. Sci. Off. Publ. Eur. Pept. Soc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7200\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:07:52Z","timestamp":1760108872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":73,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25137200"],"URL":"https:\/\/doi.org\/10.3390\/ijms25137200","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}